ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Creative Biolabs’ Innovative Microbial Identification Solutions Propel Live Biotherapeutic Research

By: Get News
Creative Biolabs, a leading Contract Research Organization (CRO), is empowering the research progress of live biotherapeutics with its state-of-the-art microbial identification services.

New York, USA - June 28, 2023 - Microbial identification services play a pivotal role in the rapidly evolving landscape of live biotherapeutics. Creative Biolabs is at the forefront, providing a range of high-quality and reliable services that facilitate in-depth analysis and characterization of microbial populations.

Creative Biolabs specializes in nucleic acid analytics, utilizing state-of-the-art molecular methods to analyze the genetic makeup of live biotherapeutic products. Through the application of advanced high-throughput sequencing technologies, scientists can swiftly detect and measure individual microbial species within intricate populations. This approach grants significant insights into the functional roles of these species, creating opportunities for precise therapeutic interventions.

Moreover, the utilization of next-generation sequencing empowers researchers to delve into the intricacies of microbial communities linked to live biotherapeutic products, uncovering their diversity and structure. This potent approach allows for the unraveling of complex relationships between microorganisms, facilitating a deeper comprehension of the ecological dynamics within the microbial ecosystem. By leveraging their expertise in next-generation sequencing techniques, Creative Biolabs excels in community analysis, offering invaluable insights for the optimization of therapeutic interventions.

Creative Biolabs offers a cost-effective whole metagenomic profiling service that covers the entire process, including high-quality genomic DNA extraction, library preparation, and sequencing using the Illumina HiSeq PE150 platform. Clients can confidently explore their metagenomic sequencing needs with the seamless and affordable solution. Additionally, this company provides a metatranscriptomics profiling service that enables researchers to study RNA transcripts within a microbial community, identify crucial pathways involved in disease progression or mitigation, and optimize the therapeutic potential of live biotherapeutic products.

A scientist at Creative Biolabs emphasizes the company's commitment to supporting researchers in advancing live biotherapeutic products: "Our microbial identification services harness the power of advanced molecular techniques, providing researchers with the critical knowledge needed to develop innovative therapeutic solutions. We are dedicated to pushing the boundaries of live biotherapeutic research."

As the demand for live biotherapeutic products continues to grow, Creative Biolabs remains at the forefront of innovation. With their high-quality microbial identification services, researchers worldwide can unlock the full potential of live biotherapeutics and revolutionize the treatment of human diseases.

Learn more, please refer to https://live-biotherapeutic.creative-biolabs.com.

About Creative Biolabs

Creative Biolabs is a highly regarded CRO that has established itself as a leader in the advancement of live biotherapeutic products. With a diverse range of services, including nucleic acid analytics, community analysis, whole metagenomic profiling, and metatranscriptomics profiling, this company offers extensive support to researchers pursuing innovative therapeutic solutions. Its expertise and comprehensive assistance empower researchers to make significant strides in the development of groundbreaking therapies.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://live-biotherapeutic.creative-biolabs.com



Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.94
+2.12 (0.98%)
AAPL  260.29
-2.23 (-0.85%)
AMD  199.45
-2.62 (-1.30%)
BAC  49.81
-0.49 (-0.97%)
GOOG  300.91
-2.54 (-0.84%)
META  660.57
-7.16 (-1.07%)
MSFT  410.68
+5.48 (1.35%)
NVDA  183.34
+0.30 (0.16%)
ORCL  154.79
+2.42 (1.59%)
TSLA  405.55
-0.39 (-0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.